Article
Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
13 Dec 2019
Abstract excerpt
Chimeric antigen receptor(CAR) T-cell therapy has shown remarkable effects and promising prospects in patients with refractory or relapsed malignancies, pending further progress in the next-generation CAR T cells with more optimized structure, enhanced efficacy and reduced toxicities. The clustered regulatory interspaced short palindromic repeat/CRISPR-associated protein 9 (CRISPR/Cas9) technology holds immense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
